Categories
Events

Prostate Cancer Related On-Line Presentations and References

The Brampton Prostate Cancer Support group has posted their October presentation and you can view it as below:

Video is now available of their Prostate Cancer Connections webinar on Genetics, Genomics, and Prostate Cancer. This important webinar was recorded on October 15th and features a panel of experts and a patient perspective segment. You can access the video now at https://youtu.be/WjkAF1xixOA.

Here is a link to Four Interesting Prostate Cancer Awareness Month (September) presentations from the Prostate Cancer Foundation of BC:

Prostate Cancer Awareness Month Speaker Series 2020

An update on an October presentation:

A note to anyone who tried to reach the October 13th presentation by Dr. Jeffrey Campbell on “Erectile Dysfunction and Urinary Incontinence after Prostate Cancer Treatment” put on by the Windsor / Essex PCS group. They offer their apologies as the link to the talk was changed at the last minute and caught them off guard. They are attempting to schedule a re-run of Dr. Campbell’s excellent presentation in November and we will let you know once they have arranged it.

Some Interesting Articles & Presentations

Walter Eadie of the Oakville / Mississauga Prostate Cancer Support group has sent along some suggested items on prostate cancer:

Here is a summary of the interesting papers and articles he has read recently:

Adding four months of androgen deprivation therapy (ADT) to radiation treatment extends survival and delays metastasis in men with unfavorable intermediate-risk prostate cancer, according to a secondary analysis of a Phase 3 clinical trial. However, that new trial analysis showed there were no such benefits to ADT therapy for men with favorable intermediate-risk prostate cancer undergoing radiation therapy. These findings support the National Comprehensive Cancer Network recommendations that ADT treatment only be given to patients with unfavorable intermediate-risk prostate cancer.

https://www.medpagetoday.com/hematologyoncology/prostatecancer/88518

A new artificial intelligence (AI) algorithm has been developed that can accurately detect and grade prostate cancer, using slide images from patient core needle prostate biopsies, a study reports. An AI system can be trained to detect and grade cancer in prostate needle biopsy samples at a ranking comparable to that of international experts in prostate pathology. https://pubmed.ncbi.nlm.nih.gov/31926806/

This is going to change everything.” Soon, you will find out your lifetime risk of getting prostate cancer through a simple saliva or blood test.

The addition of the radiotracer fluciclovine to positron-emission tomography (PET) imaging for treatment planning led to superior failure-free survival compared with conventional imaging in men with prostate cancer who had undergone radical prostatectomy and were experiencing biologic recurrence of their cancer.”

https://ascopost.com/news/october-2020/fluciclovine-pet-imaging-vs-conventional-imaging-in-prostate-cancer/?bc_md5=ce6d480b891e3ade6a267c9f9bc5f3fa&utm_source=TAP-EN-102720&utm_medium=email&fbclid=IwAR1etpN4_hj_QzdyLK0DAnbYasn3oHaj921H3UKzPscDTGKG6JAME0FMHWg


Note, fluciclovine (brand name Axumin) is FDA approved for use in PC. PSMA/PET, which is claimed to be even better, is not yet approved but that is expected within months.

Expanding on the above – here is a recording of the best review of PSMA/PET imaging that I have seen – how and when it can be used and how it can change the treatment plan for a patient

https://www.gotostage.com/channel/586ae7e307c64183ad184b75a06a255c/recording/c8bb2ed2fd3a4d1bb075882755b9d84b/watch?source=CHANNEL

Here is something coming up on the same topic from the support community in the U. S.

Prostate Cancer Connections, Imaging and Prostate Cancer Webinar

Tuesday, November 24, 2020 7:00-8:30pm Central

Register at: www.ustoo.org/connections